To understand the adverse effects which is produced by using nutritional supplements

Assessing The Safety Of Nutraceuticals Through A Nutrivigilance Approach And To Develop A Surveillance System For Monitoring Adverse Events Associated With Nutraceuticals - NIL

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/12/098460

Enrollment

250

Registered

2025-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nutraceuticals: Post marketing surveillance study on nutraceuticals. The study will be conducted for a period of 4 years. And once enrolled the patient will be under follow up for 6 mon

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients of all ages, from paediatric to geriatric populations who are willing to enrol into study after filling the informed consent form, who should be available for revisits and follow-ups of minimum 06 months until reaching the required study endpoints will be enrolled. 2)Patient taking nutraceuticals

Exclusion criteria

Exclusion criteria: 1) Patients who have not taken the dietary supplement categorized as nutraceuticals as directed by the manufacturer or healthcare professional. 2) Chronic and severely ill patients.

Design outcomes

Primary

Measure	Time frame
To assess the safety of commonly used nutraceuticals and to develop a surveillance system for use of nutraceuticals.Timepoint: 4 years	—

Secondary

Measure	Time frame
Number of ADR reportedTimepoint: 4 years	—

Countries

India

Contacts

Public ContactDr B J Mahendra Kumar

Sri Adichunchangiri College of Pharmacy

bjmahendra2003@gmail.com8547803383

Outcome results